Ovid Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

CEO

Jeremy Max Levin

CEOJeremy Max Levin

Employees

Employees23

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2014

Founded2014

Employees

Employees23

OVID Key Statistics

Market cap

42.71M

Market cap42.71M

Price-Earnings ratio

-1.42

Price-Earnings ratio-1.42

Dividend yield

—

Dividend yield—

Average volume

1.50M

Average volume1.50M

High today

$0.5179

High today$0.5179

Low today

$0.4785

Low today$0.4785

Open price

$0.4879

Open price$0.4879

Volume

535.92K

Volume535.92K

52 Week high

$1.47

52 Week high$1.47

52 Week low

$0.2425

52 Week low$0.2425

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.

Ovid Therapeutics

Why Robinhood?

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY. Show more

OVID Key Statistics

Analyst ratings

100%

People also own

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.